Human HLA-DR Fluorescein-conjugated Antibody
R&D Systems, part of Bio-Techne | Catalog # FAB4869F
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Accession # P01903
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human HLA-DR Fluorescein-conjugated Antibody
Detection of HLA‑DR in Human Blood Lymphocytes by Flow Cytometry.
Human peripheral blood lymphocytes were stained with (A) Mouse Anti-Human HLA-DR Fluorescein-conjugated Monoclonal Antibody (Catalog # FAB4869F) or (B) isotype control antibody (Catalog # IC002F) and Mouse anti-Human CD19 APC-conjugated Monoclonal Antibody (Catalog # FAB4867A). View our protocol for Staining Membrane-associated Proteins.Applications for Human HLA-DR Fluorescein-conjugated Antibody
Flow Cytometry
Sample: Human peripheral blood lymphocytes
Formulation, Preparation, and Storage
Purification
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, 2 to 8 °C as supplied.
Background: HLA-DR
HLA-DR is a transmembrane human major histocompatibility complex 2 (MHC II) family member and consists of a 34 kDa (alpha) subunit and one of several 28 kDa (beta) subunits. HLA-DR is expressed primarily by B cells and dendritic cells (DC), in which it binds peptides derived from internalized and processed antigenic proteins. It presents these peptides on the cell surface for recognition by the T cell receptor on CD4+ T cells. This interaction is central to antigen specificity in the adaptive immune response. HLA-DR alleles, polymorphisms, and aberrant expression are linked to a variety of diseases including autoimmunity and cancer.
Long Name
Alternate Names
Entrez Gene IDs
Gene Symbol
UniProt
Additional HLA-DR Products
Product Documents for Human HLA-DR Fluorescein-conjugated Antibody
Product Specific Notices for Human HLA-DR Fluorescein-conjugated Antibody
For research use only